[1]
Regmi, Y., Sapkota, G. and Wagle, B. 2019. Role of Intravenous Ketamine as Adjuvant to Opioids in Refractory Cancer Pain: Case Report. Nepalese Journal of Cancer. 3, 1 (Oct. 2019), 49–53. DOI:https://doi.org/10.3126/njc.v3i1.25916.